Media

• January 11-12, 2024, Oral Invitation, Vietnam National Cancer Hospital, Hanoi, Vietnam, “Strategy in Locally Advanced Cervical Cancer for Outcome Improvement”, Attendance in person: 70
• January 17-18, Oral Invitation, “Hybrid Brachytherapy in Locally Advanced Cervical Cancer”, Speaker: Jyoti Mayadev, MD, Hoi Chi Mihn Public K Hospital  attendees in person: 70, online zoom: 50
• Oral Invitation, “Brachytherapy for Cervical Cancer”, St. Lukes Medical Center, Manila, Philippines, March 22, attendance in person: 70
• Oral Invitation, “Strategies for Outcome Improvement in Cervical Cancer”,  March 21 2024, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia School of Medicine, Jakarta, Indonesia, attendance: 50
• Oral Invitation, “Immunotherapy toxicities with GYN RT”, Ohio State University, via zoom, attendance: 20, April 26, 2024
• Oral and panel invitation, “Starting a brachytherapy program 101”, American Brachytherapy Society Annual Meeting 2024, Washington DC
• Oral Invitation, “Cervical Cancer Treatment after KEYNOTE A18” Korean GOG 30^th Annual Meeting, Denver CO, July 26, 2024
• Oral Invitation, “Hybrid Brachytherapy for Cervical Cancer,” Chartrounds India, Aug 8, 2024, virtual zoom attendance: 75
• Oral Invited Visiting Professor and Grand Rounds, “Novel Strategies in Cervical Cancer,” University of Washington Medical Center, Seattle, WA, August 16, 2024, Zoom: 70 participants
• Oral Invited Talk and Panelist, China Immunotherapy Forum in Gynecological Oncology (Merck sponsored), “Immunotherapy and Radiation in Locally Advanced Cervical Cancer”, Aug 17, 2024, via zoom: participants 100
• Oral Invited Grand Rounds, UCSD RMAS Department “Cervical Cancer Innovation through Clinical Trial Development and Global Training,” Sept 16, 2024, via zoom: participants in person 60, via zoom 57
• Oral Invitation, “Transforming Brachytherapy for Cervical Cancer in Southeast Asia Through Tailored Collaborative Programs”, Sept 24, 2024.  Virtual zoom attendance:
• Oral Invitation, ASTRO Annual Meeting, Washington DC, Sept 27-30, 2024, “Sentinel lymph node biopsy for cervical cancer”, In person attendance: 60
• Oral Panel Invitation, Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Consensus Conference, Oct 13-15, 2024, Dublin, Ireland; co-chair of the locally advanced group 3 (w co-chair Dominica Lorusso)

• Mayadev, Chemoradiation for Stage 3 cervical cancer

• Mayadev, J: Jyoti Mayadev, MD, Provides Perspective on Atezolizumab in Locally Advanced Cervical Cancer
• Mayadev, J. Advances in Immunotherapy for Cervical Cancer: Recent Developments and Future Directions
• Mayadev, J. CALLA clinical trial updates: VDJ Onoclogy

NRG Oncology press release for GOG 9929

GOG 9929 clinical trial shows that immunotherapy after chemoradiaion in node positive cervical cancer is safe and effective with an increase in PD-1 expression.

• Mayadev, J: Invite, KUSI San Diego local news, cervical cancer novel treatments, Jan 28, 2020 
• Mayadev, J: Invite, KUSI San Diego local news, cervical cancer prevention, Jan 9, 2020 
• Mayadev, J: Oncology Live feature CALLA study, April 2020
• Mayadev, J: Invite, KUSI San Diego local news, processed meat consumption can be detrimental to health, Feb 11, 2020
• Mayadev J, Nunes AT, Li M, et al. CALLA: OncLive article link on CALLA cervical clinical trial
• UCSD Health Screening and Prevention